August 2009 Subject: Important Changes in the CellCept® (mycophenolate mofetil) Prescribing Information – Reports of Pure Red Cell Aplasia (PRCA) in Patients Treated with CellCept Dear Health Car - Mycophenolate mofetil - Document - PDFSEARCH.IO

First Page		Document Content
Medicine Lactones Phenols Mycophenolic acid Mycophenolate mofetil Pure red cell aplasia Azathioprine Tacrolimus Immunosuppressive drug Immunosuppressants Chemistry Organic chemistry		August 2009 Subject: Important Changes in the CellCept® (mycophenolate mofetil) Prescribing Information – Reports of Pure Red Cell Aplasia (PRCA) in Patients Treated with CellCept Dear Health Car Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 117,88 KB Share Document on Facebook

	Oragnic Cellular Abstract DocID: 1qFEH - View Document
	AZATHIOPRINE / 6-MERCAPTOPURINE TREATMENT FOR IBD PATIENTS INFORMATION SHEET This information leaflet is designed to answer common questions patients ask about their medicine. Further information can be found in the in DocID: 1qAnH - View Document
	------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis  Recommended dose of XELJANZ is 5 mg twice daily. (2.1)  Moderate and severe renal impairment and moderate hepatic impairme DocID: 1m0Le - View Document
	In renal transplant patients at high-immunologic risk • Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily mainten DocID: 1lhSD - View Document
	NEDERLANDS TIJDSCHRIFT VOOR DERMATOLOGIE EN VENEREOLOGIE \| VOLUME 24 \| NUMMER 05 \| meiSamenvatting Azathioprine wordt regelmatig voorgeschreven als tweede keuze oraal immunosuppressivum bij de behandeling van erns DocID: 1dYbe - View Document